20 October 2017
News and Views
Links and Services
Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis, reports the latest issue of Gastroenterology.
It is not clear why some patients with ulcerative colitis (UC) do not respond to treatment with a
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors